Skip to main content

Ontario recommends people aged 18 to 24 take Pfizer over Moderna

Share
TORONTO -

 An increase in cases of a rare heart condition in young adults who have received the COVID-19 Moderna vaccines has prompted Ontario to recommend the Pfizer-BioNTech shots for those aged 18 to 24.

The province says the rise of myocarditis and pericarditis cases has been particularly observed among males in that age group.

Between June and August, the province says the risk of myocarditis and pericarditis for males aged 18 to 24 following a second dose of Moderna was one in 5,000.

For those who received the Pfizer-BioNTech, the rate was one in 28,000.

The province says the side-effect is still rare and the majority of cases are considered mild.

The recommendation is preferential and people can still take the Moderna vaccines if they choose to.

This report by The Canadian Press was first published Sept. 29, 2021.

CTVNews.ca Top Stories

One year in, war casts a shadow over every aspect of life in Israel

As Israel's war with Hamas reaches its one-year mark, it can seem on the surface that much of life in the country has returned to normal. But with many still reeling from Hamas' Oct. 7 attack, hostages remaining in captivity and a new front of war with Hezbollah in the north, many Israelis feel depressed, despondent and angry as the war stretches into its second year.

What to know about fighting in Lebanon and Gaza

Relentless Israeli airstrikes pounded Beirut's southern suburbs overnight and closed off the main highway linking Lebanon with Syria, forcing fleeing civilians to cross the border by foot.

Local Spotlight

Stay Connected